1-3 of 3
Mario Giunta
Close
Sort by
Journal Articles

Prospective Evaluation of the International Prognostic Score (IPS) in All Stages of Hodgkin’s Lymphoma Treated with ABVD Plus Involved-Field Radiotherapy (IFRT).

Santiago Pavlovsky, Claudia Corrado, Miguel A Pavlovsky, Virginia Prates, Lucia Zoppegno, Mario Giunta, Ider Cerutti, Elsa Palomino, Graciela Avila, Francisco Lastiri
Journal: Blood
Blood (2008) 112 (11): 1454.
https://doi.org/10.1182/blood.V112.11.1454.1454
Published: 2008
Journal Articles

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Santiago Pavlovsky, MD, PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Virginia Prates, MD, Lucia Zoppegno, MD, Mario Giunta, MD, Ider Cerutti, MD, Elsa Palomino, MD, Fernando Pagani, MD, Francisco Lastiri, MD, Maria C. Narbaitz, MD, Fernando Cavagnaro, MD, Graciela Avila, MD
Journal: Blood
Blood (2006) 108 (11): 2474.
https://doi.org/10.1182/blood.V108.11.2474.2474
Published: 2006
Journal Articles

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Santiago Pavlovsky, MD PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Mario Giunta, MD, Lucia Zoppegno, MD, Virginia Prates, MD, Francisco Lastiri, PhD, Ider Cerutti, MD, Maria C. Narbaitz, MD, Silvia Rudoy, MD, Fernando Cavagnaro, MD, Alejandra Kurchan, MD, Elsa Palomino, MD, Cesar Campo, MD
Journal: Blood
Blood (2004) 104 (11): 1310.
https://doi.org/10.1182/blood.V104.11.1310.1310
Published: 2004